| Title : Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice - Salim_2017_Vascul.Pharmacol_96-98_19 |
| Author(s) : Salim HM , Fukuda D , Higashikuni Y , Tanaka K , Hirata Y , Yagi S , Soeki T , Shimabukuro M , Sata M |
| Ref : Vascul Pharmacol , 96-98 :19 , 2017 |
| Abstract : Salim_2017_Vascul.Pharmacol_96-98_19 |
| ESTHER : Salim_2017_Vascul.Pharmacol_96-98_19 |
| PubMedSearch : Salim_2017_Vascul.Pharmacol_96-98_19 |
| PubMedID: 28347868 |
Salim HM, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M (2017)
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice
Vascul Pharmacol
96-98 :19
Salim HM, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M (2017)
Vascul Pharmacol
96-98 :19